✦ LIBER ✦

Erratum to “Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes” [Bioorg. Med. Chem. Lett. 22 (2012) 1464–1468]

✍ Scribed by Jon M. Sutton; David E. Clark; Stephen J. Dunsdon; Garry Fenton; Amanda Fillmore; Neil V. Harris; Chris Higgs; Chris A. Hurley; Sussie L. Krintel; Robert E. MacKenzie; Alokesh Duttaroy; Eric Gangl; Wiesia Maniara; Richard Sedrani; Kenji Namoto; Nils Ostermann; Bernd Gerhartz; Finton Sirockin; Jörg Trappe; Ulrich Hassiepen; Daniel K. Baeschlin

Book ID: 113496664
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 162 KB
Volume: 22
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2012.01.109

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to “Phenylalanine derivative

Corrigendum to “Phenylalanine derivatives as GPR142 agonists for the treatment of Type II diabetes” [Bioorg. Med. Chem. Lett. 22 (2012) 6218–6223]

✍ Du, Xiaohui; Kim, Yong-Jae; Lai, SuJen; Chen, Xi; Lizarzaburu, Mike; Turcotte, S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Corrigendum to “The design and synthesis

Corrigendum to “The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of Type 2 diabetes mellitus” [Bioorg. Med. Chem. Lett. 22 (2012) 7100–7105]

✍ Pfefferkorn, Jeffrey A.; Tu, Meihua; Filipski, Kevin J.; Guzman-Perez, Angel; Bi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 185 KB